Should pioglitazone be used in most patients with abnormal glucose metabolism following an ischemic stroke or TIA?

Yes - all except those with a contraindication
0% (0 votes)
Some but not most - ADEs limit wide use
35% (9 votes)
No - risks outweigh benefits for most patients
46% (12 votes)
Haven't decided yet
19% (5 votes)
Total votes: 26